PIMA542071
Ascrinvacumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542071-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542071 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Ascrinvacumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
PF-03446962
Immunogen
Human ACVRL1/SKR3/TGF-B/ TSR-I
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
0.45 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG2 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Ascrinvacumab has been used in trials studying the treatment and basic science of Neoplasms, Advanced Solid Tumors, Carcinoma, Hepatocellular, and Malignant Pleural Mesothelioma.
Compare Similar Items
Show Difference
Antigen: Ascrinvacumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: PF-03446962
Immunogen: Human ACVRL1/SKR3/TGF-B/ TSR-I
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.45 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Ascrinvacumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
PF-03446962
Immunogen:
Human ACVRL1/SKR3/TGF-B/ TSR-I
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.45 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Monalizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: humZ270; IPH-2201; NN-8765; NNC-0141-0000-0100; NNC-141-01000
Immunogen: Human KLRC1/NKG2A/CD159a/CD94
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: purified
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Monalizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
humZ270; IPH-2201; NN-8765; NNC-0141-0000-0100; NNC-141-01000
Immunogen:
Human KLRC1/NKG2A/CD159a/CD94
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
purified
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Plozalizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: hu1D9; MLN-1202
Immunogen: Human CCR2/CD192
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.7 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Plozalizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
hu1D9; MLN-1202
Immunogen:
Human CCR2/CD192
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.7 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Risankizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BI 655066; risankizumab-rzaa
Immunogen: Human IL23A
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Risankizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BI 655066; risankizumab-rzaa
Immunogen:
Human IL23A
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG1 κ